롱

$IMMU can rise in the next days

업데이트됨

Contextual immersion trading strategy idea.

The demand for shares of Immunomedics looks higher than the supply.

It is a clinical-stage biopharmaceutical company, which develops monoclonal antibody-based products for the targeted treatment of cancer.

On 06APR the company announced that its Phase 3 confirmatory ASCENT study will be halted due to compelling evidence of efficacy. This drug has the potential to be the first FDA-approved conjugate for the treatment of metastatic triple-negative breast cancer — finance.yahoo.com/news/immunomedics-announces-ascent-study-stopped-120010868.html.

This and other conditions can cause a rise in the share price in the next days.

So I opened a long position from $19,37;
stop-loss — $18,60.

Information about take-profits will be later.

Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.

If you like my content, you can subscribe to the news and receive my fresh ideas.

Thanks for being with me!

매매 수동청산

1/2 closed at $20,91

액티브 트레이드

1/2 still opened

매매 수동청산

1/2 closed at $20,15